{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:40:50Z","timestamp":1777336850126,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s13555-018-0249-y","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T11:30:41Z","timestamp":1529926241000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations"],"prefix":"10.1007","volume":"8","author":[{"given":"Chiel Cristiano F.","family":"Ebbelaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aalt W.","family":"Venema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"issue":"11","key":"249_CR1","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/jdv.14349","volume":"31","author":"F Anzengruber","year":"2017","unstructured":"Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol. 2017;31(11):1775\u201391.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"249_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1203475416650427","volume":"20","author":"Y Asai","year":"2016","unstructured":"Asai Y, Tan J, Baibergenova A, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg. 2016;20(5):432\u201345.","journal-title":"J Cutan Med Surg"},{"key":"249_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13555-016-0106-9","volume":"6","author":"A Bewley","year":"2016","unstructured":"Bewley A, Fowler J, Sch\u00f6fer H, Kerrouche N, Rives V. Erythema of rosacea impairs quality of life: results of a meta-analysis. Dermatol Ther (Heidelb). 2016;6:237\u201347.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"249_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40257-015-0150-8","volume":"16","author":"ED Deeks","year":"2015","unstructured":"Deeks ED. Ivermectin: a review in rosacea. Am J Clin Dermatol. 2015;16:447\u201352.","journal-title":"Am J Clin Dermatol"},{"key":"249_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1365-4632.2004.02253.x","volume":"44","author":"AL Dourmishev","year":"2005","unstructured":"Dourmishev AL, Dourmishev LA, Schwartz RA. Ivermectin: pharmacology and application in dermatology. Int J Dermatol. 2005;44:981\u20138.","journal-title":"Int J Dermatol"},{"key":"249_CR6","doi-asserted-by":"crossref","unstructured":"Mendieta Eckert M, Landa Gundin N. Treatment of rosacea with topical ivermectin cream: a series of 34 cases. Dermatol Online J. 2016;22(8).","DOI":"10.5070\/D3228032169"},{"key":"249_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000444082","volume":"232","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study. Dermatology. 2016;232:208\u201313.","journal-title":"Dermatology"},{"key":"249_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","volume":"25","author":"BE Elewski","year":"2011","unstructured":"Elewski BE, Draelos Z, Dr\u00e9no B, Jansen T, Layton A, Picardo M. Rosacea\u2013global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011;25:188\u2013200.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"249_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2340\/00015555-2528","volume":"97","author":"FMN Forton","year":"2017","unstructured":"Forton FMN, De Maertelaer V. Two consecutive standardized skin surface biopsies: an improved sampling method to evaluate Demodex density as a diagnostic tool for rosacea and demodicosis. Acta Derm Venereol. 2017;97:242\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"249_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaad.2004.05.034","volume":"52","author":"F Forton","year":"2005","unstructured":"Forton F, Germaux MA, Brasseur T, et al. Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol. 2005;52(1):74\u201387.","journal-title":"J Am Acad Dermatol"},{"key":"249_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2133.1993.tb00261.x","volume":"128","author":"F Forton","year":"1993","unstructured":"Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case controlled study using standardised skin surface biopsy. Br J Dermatol. 1993;128:650\u20139.","journal-title":"Br J Dermatol"},{"key":"249_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jdv.13748","volume":"31","author":"B Halioua","year":"2017","unstructured":"Halioua B, Cribier B, Frey M, Tan J. Feelings of stigmatization in patients with rosacea. J Eur Acad Dermatol Venereol. 2017;31:163\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"249_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/exd.13143","volume":"26","author":"AD Holmes","year":"2017","unstructured":"Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol. 2017;26:659\u201367.","journal-title":"Exp Dermatol"},{"key":"249_CR14","first-page":"325","volume":"15","author":"LH Kircik","year":"2016","unstructured":"Kircik LH, Del Rosso JQ, Layton AM, Schauber J. Over 25 years of clinical experience with ivermectin: an overview of safety for an increasing number of indications. J Drugs Dermatol. 2016;15:325\u201332.","journal-title":"J Drugs Dermatol"},{"key":"249_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16540","author":"N Lacey","year":"2018","unstructured":"Lacey N, Russell-Hallinan A, Zouboulis CC, Powell FC. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea. Br J Dermatol. 2018. https:\/\/doi.org\/10.1111\/bjd.16540.","journal-title":"Br J Dermatol"},{"key":"249_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2340\/00015555-1976","volume":"95","author":"MM van der Linden","year":"2015","unstructured":"van der Linden MM, van Rappard DC, Daams JG, et al. Health-related quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol. 2015;95:395\u2013400.","journal-title":"Acta Derm Venereol"},{"key":"249_CR17","doi-asserted-by":"crossref","unstructured":"McGregor S, Alinia H, Snyder A, Tuchayi SM, Fleischer A, Feldman SR, A review of the current modalities for the treatment of papulopustular rosacea. Dermatol Clin. 2018;;36(2):135\u2013150.","DOI":"10.1016\/j.det.2017.11.009"},{"key":"249_CR18","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1111\/jdv.13801","volume":"30","author":"K Raoufinejad","year":"2016","unstructured":"Raoufinejad K, Mansouri P, Rajabi M, et al. Efficacy and safety of permethrin 5% topical gel vs. placebo for rosacea: a double-blind randomized controlled clinical trial. J Eur Acad Dermatol Venereol. 2016;30:2105\u201317.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"249_CR19","first-page":"768","volume":"11","author":"M Reinholz","year":"2013","unstructured":"Reinholz M, Tietze JK, Kilian K, et al. Rosacea\u2013S1 guideline. J Dtsch Dermatol Ges. 2013;11(8):768\u201380 (768\u201379).","journal-title":"J Dtsch Dermatol Ges"},{"key":"249_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bjd.13783","volume":"173","author":"EC Sattler","year":"2015","unstructured":"Sattler EC, Hoffmann VS, Ruzicka T, et al. Reflectance confocal microscopy for monitoring the density of Demodex mites in patients with rosa- cea before and after treatment. Br J Dermatol. 2015;173:69\u201375.","journal-title":"Br J Dermatol"},{"key":"249_CR21","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/jdv.14437","volume":"31","author":"M Schaller","year":"2017","unstructured":"Schaller M, Gonser L, Belge K, et al. Dual anti-inflammatory and antiparasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol. 2017;31:1907\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"249_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bjd.15173","volume":"176","author":"M Schaller","year":"2017","unstructured":"Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:465\u201371.","journal-title":"Br J Dermatol"},{"issue":"1","key":"249_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1186\/s40064-016-2819-8","volume":"5","author":"K Siddiqui","year":"2016","unstructured":"Siddiqui K, Stein Gold L, Gill J. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis. Springerplus. 2016;5(1):1151.","journal-title":"Springerplus"},{"key":"249_CR24","first-page":"1380","volume":"13","author":"L Stein Gold","year":"2014","unstructured":"Stein Gold L, Kircik L, Fowler J, et al. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. J Drugs Dermatol. 2014;13:1380\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"249_CR25","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s12325-016-0380-z","volume":"33","author":"M Steinhoff","year":"2016","unstructured":"Steinhoff M, Vocanson M, Voegel JJ, Hacini-Rachinel F, Sch\u00e4fer G. Topical ivermectin 10\u00a0mg\/g and oral doxycycline 40\u00a0mg modified-release: current evidence on the complementary use of anti-inflammatory rosacea treatments. Adv Ther. 2016;33(9):1481\u2013501.","journal-title":"Adv Ther."},{"key":"249_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/jdv.13537","volume":"30","author":"A Taieb","year":"2016","unstructured":"Taieb A, Khemis A, Ruzicka T, et al. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study. J Eur Acad Dermatol Venereol. 2016;30:829\u201336.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"249_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/bjd.13408","volume":"172","author":"A Taieb","year":"2015","unstructured":"Taieb A, Ortonne JP, Ruzicka T, et al. Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol. 2015;172(4):1103\u201310.","journal-title":"Br J Dermatol"},{"key":"249_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12385","volume":"169","author":"J Tan","year":"2013","unstructured":"Tan J, Blume-Peytavi U, Ortonne JP, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169:555\u201362.","journal-title":"Br J Dermatol"},{"key":"249_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/bjd.15122","volume":"176","author":"J Tan","year":"2017","unstructured":"Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:431\u20138.","journal-title":"Br J Dermatol"},{"key":"249_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72:749\u201358.","journal-title":"J Am Acad Dermatol"},{"key":"249_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1067\/mjd.2002.120625","volume":"46","author":"J Wilkin","year":"2002","unstructured":"Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"249_CR32","first-page":"896","volume":"146","author":"YA Zhao","year":"2010","unstructured":"Zhao YA, Wu LP, Peng Y, et al. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010;146(8):896\u2013902.","journal-title":"Arch Dermatol"},{"key":"249_CR33","first-page":"CD003262","volume":"4","author":"EJ van Zuuren","year":"2015","unstructured":"van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database Syst Rev. 2015;4:CD003262.","journal-title":"Cochrane Database Syst Rev"},{"key":"249_CR34","first-page":"316","volume":"13","author":"L Stein","year":"2014","unstructured":"Stein L, Kircik L, Fowler J, et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol 2014;13:316\u201323.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"249_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/archderm.134.6.679","volume":"134","author":"MV Dahl","year":"1998","unstructured":"Dahl MV, Katz HI, Krueger GG, Millikan LE, Odom RB, Parker F, Wolf JE Jr, Aly R, Bayles C, Reusser B, Weidner M, Coleman E, Patrignelli R, Tuley MR, Baker MO, Herndon JH Jr, Czernielewski JM. Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998;134(6):679\u201383.","journal-title":"Arch Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-018-0249-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0249-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:29:07Z","timestamp":1724412547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-018-0249-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s13555-018-0249-y","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"18 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}